Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 5.32%72.24M | -15.17%189.94M | -19.29%68.6M | 0.30%223.91M | -36.13%84.99M | -14.46%223.24M | --133.07M | -0.17%260.97M | ---- | 12.69%261.43M |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | -269.42%-5.16M | ---- | 615.18%3.04M | ---- | 12.24%-590.95K | --77.03K | 6.41%-673.4K | ---- | ---719.54K |
| Impairment and provisions: | -33.58%13.41M | 68.56%41.58M | -5.99%20.19M | -12.32%24.67M | 133.40%21.47M | -2.60%28.13M | --9.2M | 217.33%28.89M | ---- | --9.1M |
| -Other impairments and provisions | -33.58%13.41M | 68.56%41.58M | -5.99%20.19M | -12.32%24.67M | 133.40%21.47M | 68.77%28.13M | --9.2M | 288.72%16.67M | ---- | --4.29M |
| Asset sale loss (gain): | ---1.57K | 50.27%-1.9M | ---- | -1,287,845.70%-3.82M | ---- | ---296.34 | ---- | ---- | ---- | 99.01%-9.74K |
| -Loss (gain) on sale of property, machinery and equipment | ---1.57K | 50.27%-1.9M | ---- | -1,287,845.70%-3.82M | ---- | ---296.34 | ---- | ---- | ---- | 99.01%-9.74K |
| Depreciation and amortization: | 4.95%191.22M | 2.56%368.18M | 4.03%182.2M | 7.04%358.99M | 6.14%175.15M | 8.91%335.39M | --165.02M | 46.70%307.95M | ---- | 90.41%209.92M |
| -Amortization of intangible assets | 2.48%32.25M | 5.31%63.66M | 11.52%31.47M | 13.44%60.46M | -0.30%28.22M | -16.70%53.29M | --28.3M | 77.36%63.98M | ---- | --36.07M |
| -Other depreciation and amortization | 1.19%14.38M | 3.85%29.13M | 3.67%14.22M | 1.60%28.05M | -1.30%13.71M | 29.91%27.6M | --13.89M | 244.43%21.25M | ---- | --6.17M |
| Financial expense | -7.14%45.99M | 14.78%88.94M | -11.96%49.52M | -41.01%77.48M | -21.11%56.25M | 11.60%131.34M | --71.31M | 13.18%117.69M | ---- | 36.17%103.99M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -796.56%-6.3M | -71.67%4.36M | -122.24%-702.37K | 143.02%15.38M | 105.52%3.16M | -200.38%-35.75M | ---57.19M | 413.62%35.61M | ---- | 7.75%-11.36M |
| Accounts receivable (increase)decrease | -873.09%-32.4M | -54.89%-109.22M | 149.64%4.19M | 19.22%-70.51M | 88.63%-8.44M | 67.18%-87.29M | ---74.28M | -39.86%-265.98M | ---- | -43.46%-190.17M |
| Accounts payable increase (decrease) | 48.35%-9.45M | -30.70%-34.58M | 80.44%-18.3M | -340.36%-26.46M | -245.20%-93.57M | -80.52%11.01M | --64.44M | 591.23%56.52M | ---- | -105.16%-11.51M |
| Special items of business | 29.56%-2.31M | -190.28%-5.87M | -28.80%-3.28M | 178.88%6.5M | -376.15%-2.55M | -117.58%-8.25M | ---535.3K | -206.70%-3.79M | ---- | ---1.24M |
| Adjustment items of business operations | -10.14%274.72M | -10.05%542.13M | 27.91%305.7M | -0.46%602.68M | -23.31%239.01M | 11.92%605.48M | 20.64%311.65M | 45.94%540.99M | --258.33M | --370.68M |
| Net cash from operations | -9.92%272.41M | -11.97%536.25M | 27.90%302.42M | 2.00%609.19M | -24.00%236.46M | 11.18%597.24M | 20.43%311.11M | 45.41%537.2M | 247.29%258.33M | 52.93%369.44M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | ---- | --1.7M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | -99.68%12.75K | 8,497.34%17.19K | 6,446.85%3.99M | -76.21%200 | -97.55%60.88K | -95.42%840.71 | 396.47%2.48M | -95.80%18.35K | -49.90%500.49K |
| Purchase of fixed assets | 52.17%-101.32M | 32.55%-352.54M | -15.77%-211.83M | 22.96%-522.65M | 48.47%-182.97M | 10.07%-678.39M | 13.66%-355.07M | 24.34%-754.36M | -47.35%-411.24M | ---997.08M |
| Sale of subsidiaries | ---- | --5.61M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | --10M | -97.12%1.2M | ---- | --41.62M | ---- | ---- | ---- | --1.11M | ---- | ---- |
| Net cash from investment operations | 56.89%-91.32M | 27.89%-344.01M | -15.76%-211.81M | 29.67%-477.04M | 48.47%-182.97M | 9.65%-678.33M | 13.66%-355.06M | 24.67%-750.76M | -52.20%-411.23M | -23.98%-996.57M |
| Net cash before financing | 99.86%181.09M | 45.47%192.24M | 69.42%90.61M | 262.97%132.15M | 221.68%53.48M | 62.03%-81.09M | 71.25%-43.95M | 65.95%-213.57M | 65.69%-152.89M | -11.54%-627.13M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -42.00%307.96M | -15.65%620.64M | 56.24%530.96M | -33.19%735.83M | -57.72%339.83M | 46.03%1.1B | 71.55%803.82M | -11.32%754.23M | -6.55%468.57M | -7.70%850.51M |
| Refund | 43.55%-264.11M | 31.93%-619.09M | -82.12%-467.84M | 16.92%-909.56M | 61.25%-256.89M | -130.72%-1.09B | -198.60%-663.01M | 10.64%-474.49M | -14.78%-222.04M | -26.68%-530.97M |
| Dividends paid - financing | 23.21%-35.33M | 12.69%-140.26M | 29.23%-46.01M | 14.23%-160.65M | 16.31%-65.01M | 6.15%-187.32M | -6.36%-77.68M | -24.22%-199.59M | ---73.04M | -206.71%-160.66M |
| Absorb investment income | ---- | ---- | ---- | --10.5M | ---- | ---- | ---- | 8.09%16M | 639.71%16M | -14.65%14.8M |
| Other items of the financing business | ---2.77M | 111.45%3.15M | ---- | -11,549.87%-27.52M | --200K | 99.50%-236.24K | ---- | -111.95%-47.04M | ---38.11M | --393.73M |
| Net cash from financing operations | -66.33%5.76M | 61.42%-135.56M | -5.63%17.11M | -94.25%-351.4M | -71.28%18.13M | -468.30%-180.9M | -58.30%63.13M | -91.34%49.12M | -37.06%151.38M | -48.90%567.41M |
| Effect of rate | ---- | ---- | ---- | ---- | ---- | ---- | ---1.47K | ---- | ---- | ---- |
| Net Cash | 73.46%186.85M | 125.85%56.68M | 50.42%107.72M | 16.31%-219.25M | 273.53%71.61M | -59.31%-261.99M | 1,369.71%19.17M | -175.36%-164.45M | 99.26%-1.51M | -110.89%-59.72M |
| Begining period cash | 14.51%447.18M | -35.96%390.5M | -35.96%390.5M | -30.05%609.75M | -30.05%609.75M | -15.87%871.74M | -15.87%871.74M | -5.45%1.04B | -5.45%1.04B | 100.10%1.1B |
| Cash at the end | 27.26%634.03M | 14.51%447.18M | -26.88%498.22M | -35.96%390.5M | -23.52%681.37M | -30.05%609.75M | -13.90%890.91M | -15.87%871.74M | 16.14%1.03B | -5.45%1.04B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Xinyong Zhonghe Certified Public Accountants (Special General Partnership) | -- | Xinyong Zhonghe Certified Public Accountants (Special General Partnership) | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | Xinyong Zhonghe Certified Public Accountants (Special General Partnership) | -- | Deloitte Touche Tohmatsu CPA LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.